Fig. 4.
Effect of eEPC-CCL19 in a lung metastasis model of HM-1 ovarian cancer cells. HM-1 cells were injected from the tail vain to form lung metastasis. After 4 days, eEPC-CCL19s were intravenously injected. This treatment markedly diminished the number of lung metastases and significantly prolonged the survival of tumor-bearing mice